Preferred Label : Esketamine;
MeSH synonym : Kataved; S-Ketamine; (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone; L-Ketamine; (-)-Ketamine;
UNII : 50LFG02TXD;
Origin ID : C000629870;
UMLS CUI : C2825616;
ATC code(s)
- ATC code(s)
- Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
https://ansm.sante.fr/tableau-marr/esketamine
2025
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine
---
https://www.has-sante.fr/jcms/p_3531740/fr/esketamine-renaudin-esketamine-analgesie
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
Esketamine Hydrochloride
emergency treatment
respiration, artificial
esketamine
evaluation of the transparency committee
analgesia
Esketamine
---
https://www.has-sante.fr/jcms/p_3538219/fr/spravato-esketamine-depression
2024
false
false
false
France
treatment outcome
administration, intranasal
insurance, health, reimbursement
antidepressive agents
esketamine
evaluation of the transparency committee
depressive disorder, Treatment-Resistant
Esketamine
---
https://www.has-sante.fr/jcms/p_3428300/fr/eskesia-esketamine-anesthesie
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Esketamine Hydrochloride
esketamine
adult
adjuvants, anesthesia
Induction of general anesthesia (procedure)
anesthesia, conduction
evaluation of the transparency committee
Esketamine
---
https://sfar.org/note-esketamine/
2022
France
scientific and technical information
Esketamine
Esketamine
---
https://www.has-sante.fr/jcms/p_3315485/fr/esketamine-renaudin-esketamine
2022
false
false
false
France
insurance, health, reimbursement
anesthesia, general
Induction of general anesthesia (procedure)
Maintenance of general anesthesia (procedure)
anesthetics, general
esketamine
infusions, intravenous
injections, intravenous
injections, intramuscular
evaluation of the transparency committee
Esketamine
---
https://www.has-sante.fr/jcms/p_3282241/fr/esketamine-idd-5mg/ml-et-25mg/ml-esketamine
2021
false
false
false
France
evaluation of the transparency committee
treatment outcome
Esketamine
Product containing only esketamine (medicinal product)
infusions, intravenous
insurance, health, reimbursement
Esketamine Hydrochloride
injections, intravenous
injections, intramuscular
esketamine
anesthesia, general
anesthetics, general
pain
ketamine
---
https://www.has-sante.fr/jcms/p_3298608/fr/spravato-28-mg-esketamine-episode-depressif-caracterise-modere-a-severe
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
nasal sprays
administration, intranasal
Esketamine
antidepressive agents
esketamine
depressive disorder, major
drug therapy, combination
adult
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3191469/fr/spravato
2020
false
false
false
France
esketamine
insurance, health, reimbursement
treatment outcome
adult
drug therapy, combination
depressive disorder, Treatment-Resistant
Esketamine
ketamine
antidepressive agents
administration, intranasal
Esketamine
antidepressive agents
evaluation of the transparency committee
Esketamine
Esketamine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/spravato
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
ketamine
ketamine
Esketamine
Esketamine
drug approval
europe
antidepressive agents
antidepressive agents
product surveillance, postmarketing
administration, intranasal
nasal sprays
adult
drug therapy, combination
depressive disorder, Treatment-Resistant
aged
drug interactions
pregnancy
breast feeding
receptors, n-methyl-d-aspartate
drug evaluation, preclinical
esketamine
Esketamine
Esketamine
---
